M. Iglesias-Rodriguez

Differential Binding of Sarilumab and Tocilizumab to IL‐6Rα and Effects of Receptor Occupancy on Clinical Parameters

P. Emery, R. Maldonado, Terra B. Potocky, 2020, Journal of clinical pharmacology.

Interleukin-6 receptor blockade or TNFα inhibition for reducing glycaemia in patients with RA and diabetes: post hoc analyses of three randomised, controlled trials

M. Genovese, M. González-Gay, K. Thangavelu, 2020, Arthritis Research & Therapy.

Evaluation of belimumab treatment in patients with systemic lupus erythematosus in a clinical practice setting: Results from a 24-month OBSErve study in Argentina

B. Pons-Estel, P. Mannucci, A. Babini, 2020, Lupus.

Medically-attended anxiety and depression is increased among newly diagnosed patients with cold agglutinin disease: Analysis of an integrated claim-clinical cohort in the United States

J. Fryzek, C. Frankenfeld, M. Iglesias-Rodriguez, 2022, PloS one.

Identification of a Rule to Predict Response to Sarilumab in Patients with Rheumatoid Arthritis Using Machine Learning and Clinical Trial Data

A. Praestgaard, J. Gottenberg, A. Schwarting, 2021, Rheumatology and Therapy.